Surviving Progress [SEP] based on
Surviving Progress
Surviving Progress is a 2011 Canadian documentary film written and directed by Mathieu Roy and Harold Crooks, loosely based on "A Short History of Progress", a book and a 2004 Massey Lecture series by Ronald Wright about societal collapse. The film was produced by Daniel Louis, Denise Robert, and Gerry Flahive.
Subject matter.
The film is structured as a series of interviews, interspersed with footage from all over the world. The film is said to be "inspired by" Wright's lectures:
of GRNVAC1, a telomerase vaccine being used on patients with prostate cancer was carried out at Duke University. Geron's progress with telomerase vaccines attracted a modest monetary investment in 2005 from Merck.
- GRN1005, an LRP-directed conjugate of paclitaxel, was in phase II clinical trials for brain cancer but discontinued based on preliminary results in 2012.
In 2014 Geron exclusively licensed imetelstat to Janssen Biotech. This partnership was ended by Janssen on Sep 28th, 2018.
Drug candidates Telomerase activation.
In addition to testing drug